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Introduction:  Cannabis  is  the  most  common  illegal  substance  used  in  the  world.  The  psychoactive  nature  of
cannabis  is primarily  due  to delta-9-tetrahydrocannabinol  (THC).  Some  research  suggests  that  prolonged
cannabinoid  use increases  its  half-life  and  fat solubility  in the body,  slowing  gastric  emptying,  leading
towards  feelings  of  nausea  and  vomiting.  We  describe  a  case  where  a 32  year  old  male  has  excessive
nausea  and vomiting  after  prolonged  use  of daily  cannabis.
Case  Report:  A  32  year  old  Hispanic  male  with  no  signiﬁcant  past medical  history  presented  to the  emer-
gency  department  with  ﬁve  days  history  of  nausea  and vomiting  associated  with  abdominal  pain. The
vomitus  is associated  with  diffuse  abdominal  pain  and is  alleviated  by  taking  hot showers.  Vital  signs were
normal  and  physical  exam  showed  some  abdominal  tenderness.  CBC  and CMP were  normal,  and  urine
toxin  screen  revealed  positivity  for THC. The  patient  was  admitted  with  possible  diagnoses  of  cannabis
induced  hyperemesis.  He  was  placed  on  Lorazepam  and  he  took  multiple  hot  showers,  which  improved
his  nausea.  The  next  day  he  was  discharged  home  in stable  condition.
Conclusion:  Our  patient  reported  the vomiting  episodes  were  associated  with  the  regular  usage  of cannabis
over  19 years.  One  theory  on  the  effectiveness  of hot  showers  states  that  it  may  correct  the  disequilib-
rium  of  the thermoregulatory  system  in  the  hypothalamus.  Another  theory  suggests  that  the  concept
of  peripheral  vasodilation  and  redistribution  of blood  ﬂow  from  the  splanchnic  circulation  to  peripheral
musculature  helps  decrease  vomiting.  This  research  gap  shows  that  further  studying  of cannabis  and  its
effects  are  still  needed.
©  2015  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an open  access  article  under  the CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).. Introduction
Cannabis is the most common illegal substance used in the
orld [1]. The psychoactive nature of cannabis is primarily due to
elta-9-tetrahydrocannabinol (THC) [2]. Cannabis has been used
or prophylaxis and treatment of nausea for a long time, espe-
ially during chemotherapy sessions [3]. The association between
annabinoid use well recognized as an anti-emetic and the link
etween chronic usage and hyperemesis is still unclear, however,
ome proposed mechanisms suggest that prolonged cannabinoid
se increases its half-life and fat solubility in the body, slowing
astric emptying and peristalsis. This in turn leads to feelings of
ausea and can progress into vomiting [4–6]. We  describe a case
here a 32 year old male has excessive nausea and vomiting after
rolonged use of daily cannabis.
∗ Corresponding author at: 530 New Brunswick Ave, Perth Amboy, NJ, USA.
E-mail address: wjehangir@hotmail.com (W.  Jehangir).
ttp://dx.doi.org/10.1016/j.toxrep.2015.05.015
214-7500/© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access
c-nd/4.0/).2. Case presentation
A 32 year old Hispanic male with no signiﬁcant past medical
history presented to the emergency department with ﬁve days
history of nausea and vomiting associated with abdominal pain.
Patient stated that he has been having 8–10 episodes of non-bloody,
non-projectile and non-bilious vomiting which is associated with
diffuse, non-radiating, colicky abdominal pain alleviated by tak-
ing hot showers. The patient also had two  days history of diarrhea
which resolved on its own. The patient denied anorexia, dysphagia,
heartburn, jaundice, hematemesis, excessive ﬂatulence, bloating,
constipation, tenesmus, hernia, fevers, chills, weakness, fatigue, or
recent weight loss. The patient had a similar episode 2 months ago
and was  admitted to the hospital, for which he had a computerized
tomography (CT) scan of the abdomen performed. At that time the
CT showed a possible diagnosis of inﬂammatory bowel disease. The
patient also has a 15 pack year history of smoking, along with social
alcohol use, and daily marijuana use for 19 years. Physical examina-
tion upon admission revealed a well-developed, Hispanic male who
 article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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as in moderate distress from pain. BP 127/70 mmHg, HR 60/min, T
7.4◦F, RR 23/min, and Oxygen saturation 97% on room air. Skin was
arm, dry, and without rash. Abdomen was soft with periumbil-
cal tenderness, and without hepatosplenomegaly. The remainder
f the physical exam was normal. Laboratory data showed revealed
b 14.2, Hct 42.6, WBC  9, and Platelets 155,000. Urine toxic screen
evealed positivity for THC and benzodiazepenes. The patient was
dmitted with possible diagnoses of cannabis induced hyperemesis
nd irritable bowel disease. He was started on empirical antibi-
tics which was  discontinued after 2 days, and he was placed on
ofran and pantoprazole for relieve of nausea, however these med-
cations failed to produce any relief. After admission, he was placed
n lorazepam 1 mg  IV which provided immediate improvement in
is nausea. During the patient’s hospital stay, he took multiple hot
howers as they relieved his vomiting and abdominal pain. The
otal course of stay for this patient was just over 24 h and he was
ymptom free prior to discharge. The patient was educated on the
annabis use being the contributory factor of his sickness and he
as advised to discontinue its use. He was prescribed Lorazapam
 mg PO BID for 3 days and then was reduced to once a day for 3
ays. He was followed up in outpatient clinic.
. Discussion
The primary hallmarks of cannabinoid hyperemesis syndrome
nclude chronic use of marijuana (usually every day for more than
 year [7], recurrent episodes of nausea and vomiting, abdominal
ain, and relief of symptoms from taking a hot shower bath. A liter-
ture search will show that there is not yet much research showing
ow hot water plays a role in alleviating the symptoms [8–11]. One
heory is that the hot showers may  correct the disequilibrium of the
hermoregulatory system in the hypothalamus [12]. It is astound-
ng as to what extremes a patient could go as to stereotypically
ump into the shower every hour since the water helps reduce the
ymptoms right away. This effect is short lived and the symptoms
o return quickly. Another treatment modality that has proven to
e effective is IV lorazepam [13]. These modalities can be effective
reatment of the symptoms associated with cannabis hyperemesis
yndrome, however, the best cure would be complete abstinence
rom cannabis use.
Another theory of the relief brought on by hot showers is the
oncept of peripheral vasodilation and redistribution of blood ﬂow
rom the splanchnic circulation to muscle that has been demon-
trated during exercise and warm bathing [14]. This would provide
emporary relief of nausea and vomiting by diverting bloodﬂow
rom the gut to the skin.
There are CB1 receptors present in the splanchnic nervous
ystem that stimulate peristalsis and vasodilation in the enteric
ystem, which in turn promotes gastric emptying. Our theory is
hat, the abdominal pain associated with cannabinoid hypereme-
is syndrome might be explained by the effects of the chronic use of
annabis and prolonged activation of CB1 receptors in the splanch-
ic nervous system, causing down regulation of the receptors and
ubsequently slowing peristalsis. In addition, there are CB1 recep-
ors in the limbic system and when stimulated, have a vasodilator
ffect as seen by conjunctival injection in marijuana users [15,16].
f this is over activated and sensitized, redistributary effect of the
asculature is lost and blood is re-directed to the core of the body.
aking hot showers causes local histamine release and vasodilation
hich maybe the relieving factor in chronic users and hyperemesis
annabinoid syndrome.
[eports 2 (2015) 889–890
4. Conclusion
Our patient reported regular usage of cannabis for almost 19
years and noticed that his symptoms get worse with usage. Further-
more, his persistent use of hot showers with symptomatic relief as
an outcome caused us to suspect cannabinoid hyperemesis syn-
drome. Most cannabis hyperemesis syndrome is not seen in ﬁrst
time users and a ﬁnding in extensive and chronic history of use. It
is rare for cannabis hyperemesis syndrome to occur with ﬁrst time
use and is rather seen with extensive chronic use. Thus, it is likely
that since THC is lipophilic in nature, it accumulates in the blood
stream resulting in toxic side effects. Therefore, it is our belief that
THC being lipophilic in nature could accumulate in fat in the brain,
viscera, and elsewhere in the body, leading to toxic effects in pro-
longed use. This shows that further studying is needed to determine
the safety and efﬁcacy of treatment of cannabis hyperemesis syn-
drome. It also goes to show that more research on cannabis is also
needed before medical recommendations can be made on using
this substance for treatment of any conditions.
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